Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients.

[1]  A. Chockalingam,et al.  Efficacy and optimal dose of sildenafil in primary pulmonary hypertension. , 2005, International journal of cardiology.

[2]  P. Robach,et al.  Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. , 2005, American journal of respiratory and critical care medicine.

[3]  M. Humbert,et al.  Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. , 2004, American journal of respiratory and critical care medicine.

[4]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[5]  V. Peinado,et al.  Pulmonary hypertension in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[6]  A. Torbicki,et al.  Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. , 2003, Journal of the American College of Cardiology.

[7]  M. Hoeper,et al.  Effects of inhaled salbutamol in primary pulmonary hypertension , 2002, European Respiratory Journal.

[8]  C. Sartori,et al.  Salmeterol for the prevention of high-altitude pulmonary edema. , 2002, The New England journal of medicine.

[9]  P. Nihoyannopoulos,et al.  Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. , 2001, The European respiratory journal.

[10]  N. Voelkel,et al.  Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? , 2000, The Journal of clinical investigation.

[11]  W. Kim,et al.  Accuracy of doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  P. Colonna,et al.  Evaluation of mean right atrial pressure by two-dimensional and Doppler echocardiography in patients with cardiac disease. , 1998, Giornale italiano di cardiologia.

[13]  B. Brundage,et al.  Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. , 1997, Journal of the American College of Cardiology.

[14]  G. Koch,et al.  Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension , 1997 .

[15]  A. Wells,et al.  Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. , 1997, British journal of rheumatology.

[16]  A. Chaouat,et al.  Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. , 1995, Chest.

[17]  S. Shinohara,et al.  Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes. , 1992, Japanese circulation journal.

[18]  P. Henricks,et al.  Mechanisms of beta-adrenergic receptor regulation in lungs and its implications for physiological responses. , 1992, Physiological reviews.

[19]  C. Ringsted,et al.  Pulmonary vasodilatation and augmentation of right ventricular function following terbutaline infusion in severe chronic pulmonary disease. , 1991, Clinical physiology.

[20]  N. Schiller,et al.  Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. , 1990, The American journal of cardiology.

[21]  J. Roca,et al.  Pulmonary gas exchange in severe chronic asthma. Response to 100% oxygen and salbutamol. , 1990, The American review of respiratory disease.

[22]  C. Ringsted,et al.  Ventilation-perfusion distributions and central hemodynamics in chronic obstructive pulmonary disease. Effects of terbutaline administration. , 1989, Chest.

[23]  R. Bevan,et al.  Influence of adrenergic innervation on vascular growth and mature characteristics. , 1989, The American review of respiratory disease.

[24]  C. Huynh,et al.  How Does Salbutamol Improve the Ventricular Performance in Patients with Chronic Obstructive Pulmonary Disease? , 1988, Journal of cardiovascular pharmacology.

[25]  D J Hagler,et al.  Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. , 1987, Journal of the American College of Cardiology.

[26]  M. Gardner,et al.  Confidence intervals rather than P values: estimation rather than hypothesis testing. , 1986, British medical journal.

[27]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[28]  J. Seward,et al.  Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. , 1985, Journal of the American College of Cardiology.

[29]  W. Zapol,et al.  Pulmonary artery remodeling and pulmonary hypertension after exposure to hyperoxia for 7 days. A morphometric and hemodynamic study. , 1984, The American journal of pathology.

[30]  P. Yock,et al.  Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. , 1984, Circulation.

[31]  A. Muir,et al.  Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale , 1984, British medical journal.

[32]  J. Bishop,et al.  Early effects of intravenous terbutaline on cardiopulmonary function in chronic obstructive bronchitis and pulmonary hypertension. , 1982, Thorax.

[33]  G. Teule,et al.  Haemodynamic effects of terbutaline in chronic obstructive airways disease. , 1980, Thorax.

[34]  E. Bergofsky,et al.  beta-Receptor influence on lung vasoconstrictor responses to hypoxia and humoral agents. , 1977, Journal of applied physiology: respiratory, environmental and exercise physiology.

[35]  T. Furuse,et al.  Echocardiographic features of primary pulmonary hypertension. , 1976, Yonago acta medica.

[36]  C. Giuntini,et al.  THE INFLUENCE OF HYDROGEN ION CONCENTRATION AND HYPOXIA ON THE PULMONARY CIRCULATION. , 1964, The Journal of clinical investigation.

[37]  E. Weitzenblum,et al.  Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[38]  Yue-ying Gu,et al.  Pulmonary hypertension in systemic lupus erythematosus , 1999, Rheumatology International.

[39]  E. Weitzenblum,et al.  Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. , 1995, Blood pressure. Supplement.

[40]  P. Barbier,et al.  A new formula for echo-Doppler estimation of right ventricular systolic pressure. , 1994, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[41]  L. Reid,et al.  Mapping of β-Adrenergic Receptors in Rat Lung: Effect of Isoproterenol , 1984 .